Northern Bitcoin AG (NB2) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Northern Bitcoin AG (Northern Bitcoin) formerly known as Biosilu Healthcare AG is a life science company that develops and commercializes biopharmaceuticals. The companys product pipeline comprises biosimilar development projects on immune disorders and cancer. It offers products in therapeutic areas of infectious diseases, fertility, tumor indications and other rare diseases. Northern Bitcoin also provides advises for Asian biopharmaceutical companies and investors in outreach to Western markets, partners and investment opportunities. The company develops products with a clinical-proof-of-concept in areas of high medical needs in Asia. It partners with western biopharmaceutical companies. The company operates in Germany and China. Northern Bitcoin is headquartered in Frankfurt, Germany.

Northern Bitcoin AG (NB2) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Northern Bitcoin AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Northern Bitcoin AG, Medical Devices Deals, 2012 to YTD 2018 9
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
amp biosimilars Enters into Licensing Agreement for ABY-021 Biosimilar 11
amp biosimilars Enters into Licensing Agreement for Biosimilar 12
Equity Offering 13
Biosilu Healthcare Raises USD0.5 Million in Private Placement of Shares 13
amp biosimilars Raises USD28.67 Million in IPO 14
Northern Bitcoin AG - Key Competitors 15
Northern Bitcoin AG - Key Employees 16
Northern Bitcoin AG - Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Northern Bitcoin AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Northern Bitcoin AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Northern Bitcoin AG, Deals By Therapy Area, 2012 to YTD 2018 8
Northern Bitcoin AG, Medical Devices Deals, 2012 to YTD 2018 9
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
amp biosimilars Enters into Licensing Agreement for ABY-021 Biosimilar 11
amp biosimilars Enters into Licensing Agreement for Biosimilar 12
Biosilu Healthcare Raises USD0.5 Million in Private Placement of Shares 13
amp biosimilars Raises USD28.67 Million in IPO 14
Northern Bitcoin AG, Key Competitors 15
Northern Bitcoin AG, Key Employees 16

List Of Figures


Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Northern Bitcoin AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Northern Bitcoin AG, Medical Devices Deals, 2012 to YTD 2018 9

Northern Oil & Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017

Northern Oil & Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from it, the industry analysis specialists, that offers comprehensive information on

USD 250 View Report

Northern Bitcoin AG (NB2) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Northern Bitcoin AG (Northern Bitcoin) formerly known as Biosilu Healthcare AG is a life science company that develops and commercializes biopharmaceuticals. The companys product pipeline comprises biosimilar development projects on

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available